Raritan Recalls Up&Up Psyllium Fiber Supplement for C. Difficile Contamination
Raritan Pharmaceuticals is recalling Up&Up Psyllium Fiber Supplement due to possible C. difficile contamination in the raw material.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves C. difficile, a high-risk pathogen associated with severe gastrointestinal illness, meeting the criteria for a Severe rating.
Plain-English summary
Raritan Pharmaceuticals, Inc. is recalling 48,120 bottles of Up&Up Psyllium Fiber Supplement. The product is a 100% natural psyllium husk fiber therapy for regularity, distributed by Target Corp. in 160-capsule bottles.
The recall is being conducted because of possible microbial contamination by C. difficile discovered in the raw material. The affected lots are 15952 (Exp 06/15), 16459, 16460, 16463 (Exp 07/15), and 16475 (Exp 08/15). The product was distributed nationwide.
Consumers should stop using the product and contact the recalling firm for instructions on how to return it or obtain a refund.
The recalled product
- Product
- Up&Up Psyllium Fiber Supplement, 100% natural psyllium husk, Fiber Therapy for Regularity/Fiber Supplement, 160 capsules per bottle, Distributed by: Target Corp., Minneapolis, MN 55403, Made in USA, NDC 11673-059-87, UPC 3-68163-11926-8.
- Manufacturer
- Raritan Pharmaceuticals, Inc.
- Category
- Drug — Dietary Supplement
- Affected units
- 48,120
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Item 119160TGT
- Lots15952
- Exp 06/15
- 16459
- 16460
- 16463
- Exp 07/15
- 16475
- Exp 08/15
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 12 recalled by Raritan Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · Raritan Pharmaceuticals, Inc.
See all →- ModerateRaritan Recalls Kids' Relief Ear Liquid Due to Manufacturing Deviations
FDA (Drugs) · 2017-01-04
- ModerateCVS Health Homeopathic Infants Teething Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2017-01-04
- ModerateRaritan Recalls CVS Kids' Ear Relief Liquid for Manufacturing Deviations
FDA (Drugs) · 2017-01-04
- SevereRaritan Recalls Leader Fiber Capsules Due to C. Difficile Contamination
FDA (Drugs) · 2012-10-31
- SevereRaritan Recalls Fiber Capsules Due to Possible C. Difficile Contamination
FDA (Drugs) · 2012-10-31
Same hazard · c difficile
See all →- HighSterling Gelatin Recalls Limed Bone Gelatin Due to C. Difficile Contamination
FDA (Drugs) · 2012-11-28
- SevereRaritan Pharmaceuticals Recalls Wal-Mucil Fiber Laxative Due to Microbial Contamination
FDA (Drugs) · 2012-10-31
- SevereEquate Fiber Therapy Recalled for Possible C. Difficile Contamination
FDA (Drugs) · 2012-10-31
- SevereRaritan Pharmaceuticals Recalls Premier Value Fiber Capsules Due to C. Difficile Contamination
FDA (Drugs) · 2012-10-31
- SevereCVS Pharmacy Fiber Capsules Recalled for Possible C. Difficile Contamination
FDA (Drugs) · 2012-10-31